(19)
(11) EP 4 288 077 A1

(12)

(43) Date of publication:
13.12.2023 Bulletin 2023/50

(21) Application number: 22706675.0

(22) Date of filing: 04.02.2022
(51) International Patent Classification (IPC): 
A61K 38/03(2006.01)
 A61P 27/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/03; A61P 27/02
(86) International application number:
PCT/IB2022/050980
(87) International publication number:
WO 2022/167987 (11.08.2022 Gazette 2022/32)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 04.02.2021 EP 21155214

(71) Applicant: Medivis S.r.l.
95030 Tremestieri Etneo, Catania (IT)

(72) Inventors:
  • SAITA, Maria Grazia
    95030 Tremestieri Etneo, Catania (IT)
  • MANGIAFICO, Sergio
    95030 Tremestieri Etneo, Catania (IT)
  • ALEO, Danilo
    95030 Tremestieri Etneo, Catania (IT)
  • MELILLI, Barbara
    95030 Tremestieri Etneo, Catania (IT)
  • SPITALERI, Fabiola
    95030 Tremestieri Etneo, Catania (IT)
  • CRO, Melina
    95030 Tremestieri Etneo, Catania (IT)

(74) Representative: Croce, Valeria et al
Jacobacci & Partners S.p.A. Via Senato, 8
20121 Milano
20121 Milano (IT)

   


(54) FORMULATION FOR THE TREATMENT OF ASTHENOPIA